An epidemiologist from the University of Indonesia Pandu Riono said the policy on using the GeNose C19 tool as a tool for examining Covid-19 before traveling should be reviewed.
According to Pandu, GeNose is still experimental, so it cannot be used for public services.
“It must be reviewed, especially since the Task Force applies it as if the level of accuracy is the same (GeNose with PCR and Rapid Test Antigen), that’s an inaccurate view,” said Pandu on Tuesday. (30/3/2021).
Pandu said the results of research on GeNose C19 have not been publicly announced. Also, in some countries, the Covid-19 detection tools such as GeNose C19 are not used because it is inaccurate in examining Covid-19.
“In other countries, there is also (a type of GeNose) but they don’t use it, because there are many false negatives. Singapore doesn’t use it, the Netherlands doesn’t use it,” he said.
Based on this, Pandu said that people who want to travel should do the Rapid Antigen Test because it is more accurate and recognized by the World Health Organization (WHO).
“Why are we playing around with testing tools, how come it’s experimental, how come you try it, I challenge whoever uses GeNose to show anyone’s level of accuracy first, prove it to the public scientifically,” he concluded.
Previously reported, the Covid-19 Handling Task Force issued Circular Letter (SE) Number 12 of 2021 concerning Travel Provisions for Domestic People During the Covid-19 Pandemic.
One of the points of rule in this Letter is that it allows air transportation travelers to use GeNose as a means of checking before traveling.
Reporting from the SE sheet on Tuesday (30/1/2021), this rule is contained in number 3 letter b which reads:
“Air transport travelers are required to show a certificate of negative RT-PCR test results, which samples were taken within a maximum period of 3 x 24 hours before departure, or negative results of the rapid antigen test, which samples were taken within a maximum period of 2 x 24 hours before departure, or negative result of the GeNose C19 test at the airport before departure as a travel requirement and filling out Indonesia’s e-HAC. “
Previously, the use of the GeNose C19 as a tool for examining new travelers was permitted for trips using intercity trains.
GeNose C19 is a tool made by Gadjah Mada University (UGM) to detect the coronavirus through exhalation.
This tool has received a distribution permit from the Ministry of Health No. Kemenkes RI AKD 20401022883.
photo by PR of PT KAI DAOP 2 BANDUNG